What is the Phase‑Sensitive Inversion‑Recovery (PSIR) MRI sequence and what are its clinical uses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

PSIR Sequence - Definition and Clinical Uses

Phase-Sensitive Inversion Recovery (PSIR) is a specialized MRI sequence that preserves the sign of magnetization during inversion recovery, eliminating background phase interference and providing superior tissue contrast without requiring precise inversion time selection.

What is PSIR?

PSIR is an advanced MRI technique that uses phase-sensitive reconstruction to convert images while maintaining inverse longitudinal magnetization as positive signal intensity 1. Unlike conventional inversion recovery sequences that require careful selection of optimal inversion time (TI), PSIR eliminates the need for TI optimization and prevents signal intensity reversal between normal and enhanced tissues 2, 3.

The sequence works by:

  • Preserving the mathematical sign of the desired magnetization during inversion recovery
  • Eliminating background phase artifacts
  • Maintaining high contrast-to-noise ratio efficiency (1.16 compared to 0.73 for T1-FLAIR and 0.23 for conventional T1-weighted sequences) 3

Primary Clinical Uses

Multiple Sclerosis - Cortical Lesion Detection

PSIR is most clinically valuable for detecting cortical and intracortical lesions in multiple sclerosis, where it demonstrates superior performance compared to other sequences 1.

Key advantages in MS imaging:

  • Cortical lesions appear hypointense relative to surrounding normal cortex on PSIR 1
  • Detects lesions involving the cortex partially or completely
  • Superior to double inversion recovery (DIR) for longitudinal detection of new cortical lesions 4
  • In progressive MS, PSIR detected cortical lesions in 88% of patients cross-sectionally and 95% longitudinally, compared to lower rates with DIR 4
  • Led to reclassification of approximately one-third of cortical lesions initially seen on DIR 4

Important caveats:

  • Artifacts are relatively common on PSIR sequences - training is essential to distinguish true lesions from artifacts and normal biological structures (e.g., cortical vessels) 1
  • Lesions should be confirmed on consecutive slices and with multiple MRI sequences 1
  • Minimum lesion size criteria: at least 3 mm along the main in-plane axis 1

Current guideline status:

While PSIR shows promise, the 2019 MAGNIMS guidelines acknowledge that PSIR (along with DIR and MPRAGE) has provided important insights but requires substantial additional research before routine diagnostic use 5. The sequences remain optional add-ons pending multicentre validation 5.

Spinal Cord Imaging

PSIR combined with T1-weighted inversion recovery shows higher lesion-to-cord contrast than STIR or fast spin-echo T2-weighted sequences for cervical spinal cord imaging 5. However, long acquisition times currently preclude routine clinical use 5.

Cardiac Imaging - Myocardial Viability

In cardiology, PSIR is established for delayed-enhancement imaging to assess myocardial viability and detect myocardial infarction 2, 6, 7, 8:

  • Eliminates need for precise TI selection that conventional inversion recovery requires
  • Prevents contrast loss from suboptimal timing
  • Can be combined with single-shot techniques for single breath-hold imaging 7
  • Maintains accurate infarct size quantification 6

Technical Considerations

PSIR requires at least 1.5T or 3.0T field strength for adequate signal-to-noise ratio 1. The sequence is more time-efficient than conventional T1-weighted spin-echo imaging (1:30 minutes versus 2:40 minutes for whole brain coverage) 3.

Practical limitations:

  • Not widely available on all clinical scanners
  • Requires standardization of acquisition parameters across manufacturers
  • Moderate inter-observer agreement necessitates reader training
  • Phase images must be saved for optimal interpretation

Bottom Line

PSIR is primarily a research and specialized clinical tool for cortical lesion detection in MS and myocardial viability assessment in cardiac imaging. For MS specifically, while it improves cortical lesion detection compared to standard sequences, it remains an optional add-on sequence pending further validation studies 5. When used, proper training to avoid artifacts and confirmation with multiple sequences is essential 1.

Related Questions

Is a morning blood pressure of 105/54 mm Hg normal, and what management is recommended if the patient is asymptomatic?
How should I manage a 10-month-old infant with a rectal temperature of 100.6 °F and two episodes of vomiting?
What is the appropriate management for a 10‑month‑old infant with cough, wheezing, coarse breath sounds, and diarrhea?
What is the recommended evaluation and management for a 10-year-old male with pubic pain, intermittent dysuria for 2–3 months, decreased appetite, and urine specific gravity of 1.015?
What is the appropriate evaluation and management for a patient with a 0.5 cm round ground‑glass opacity in the right upper lung who has been exposed to chemicals and now presents with a chronic cough?
What is the MRI SWAN (Susceptibility Weighted Angiography) sequence and when should it be used?
Can non‑alcoholic chronic liver disease present with a high‑sensitivity C‑reactive protein (hsCRP) level of 70 mg/L?
In an elderly adult being evaluated for cognitive decline, seizures, or focal neurological deficits, when should a Phase‑Sensitive Inversion‑Recovery (PSIR) sequence be added to the brain MRI protocol, and what are the recommended imaging parameters?
What is Magnetization‑Prepared Rapid Gradient‑Echo (MPRAGE), including its typical imaging parameters and clinical applications?
What is the recommended dosing regimen for Slow‑K (extended‑release potassium chloride) tablets in adults with hypokalemia?
What is the appropriate diagnostic and therapeutic approach for a 39-year-old obese male presenting with a 6-month history of decreased libido and stamina, tachycardia, borderline diastolic hypertension, and chronic alcohol consumption of 100 mL daily for 10–15 years?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.